» Authors » Nuno A Fonseca

Nuno A Fonseca

Explore the profile of Nuno A Fonseca including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 76
Citations 4131
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Cabezas M, Fonseca N, Munoz-Merida A
Environ Microbiome . 2024 Nov; 19(1):88. PMID: 39522045
Motivation: Accurate determination and quantification of the taxonomic composition of microbial communities, especially at the species level, is one of the major issues in metagenomics. This is primarily due to...
2.
Biscaia-Caleiras M, Fonseca N, Lourenco A, Moreira J, Simoes S
J Control Release . 2024 Jul; 373:617-639. PMID: 39002799
Lipid-based complex injectables are renowned for their effectiveness in delivering drugs, with many approved products. While significant strides have been made in formulating nanosystems for small molecular weight drugs, a...
3.
Guedes J, Ribeiro R, Carqueijeiro I, Guimaraes A, Bispo C, Archer J, et al.
J Exp Bot . 2023 Oct; 75(1):274-299. PMID: 37804484
Catharanthus roseus leaves produce a range of monoterpenoid indole alkaloids (MIAs) that include low levels of the anticancer drugs vinblastine and vincristine. The MIA pathway displays a complex architecture spanning...
4.
Rheinbay E, Nielsen M, Abascal F, Wala J, Shapira O, Tiao G, et al.
Nature . 2023 Jan; 614(7948):E40. PMID: 36697832
No abstract available.
5.
Calabrese C, Davidson N, Demircioglu D, Fonseca N, He Y, Kahles A, et al.
Nature . 2023 Jan; 614(7948):E37. PMID: 36697831
No abstract available.
6.
Zhang Y, Chen F, Fonseca N, He Y, Fujita M, Nakagawa H, et al.
Nat Commun . 2022 Dec; 13(1):7572. PMID: 36481652
No abstract available.
7.
Garg M, Couturier D, Nsengimana J, Fonseca N, Wongchenko M, Yan Y, et al.
Nat Commun . 2022 May; 13(1):2841. PMID: 35581257
No abstract available.
8.
Valerio-Fernandes A, Fonseca N, Goncalves N, Cruz A, Pereira M, Gregorio A, et al.
Cancers (Basel) . 2022 May; 14(9). PMID: 35565346
Notwithstanding the advances in the treatment of lung cancer with immune checkpoint inhibitors, the high percentage of non-responders supports the development of novel anticancer treatments. Herein, the expression of the...
9.
Egeter B, Verissimo J, Lopes-Lima M, Chaves C, Pinto J, Riccardi N, et al.
Mol Ecol Resour . 2022 Mar; 22(6):2232-2247. PMID: 35305077
Traditional detection of aquatic invasive species via morphological identification is often time-consuming and can require a high level of taxonomic expertise, leading to delayed mitigation responses. Environmental DNA (eDNA) detection...
10.
Cruz A, Fonseca N, Malheiro A, Melo J, Gaspar M, Fernandes R, et al.
Eur J Pharm Biopharm . 2022 Feb; 172:61-77. PMID: 35104605
One of the major assets of anticancer nanomedicine is the ability to co-deliver drug combinations, as it enables targeting of different cellular populations and/or signaling pathways implicated in tumorigenesis and...